Pharmacokinetics News and Research

RSS
The term pharmacokinetics is derived from the ancient Greek words “pharmakon” and “kinetikos”, meaning “drug” and “putting in motion” respectively. It is one of the main branches of pharmacology, and refers to the way that the body reacts on and affects a pharmaceutical substance in the body.
The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

Topical antiseptic Acriflavine inhibits SARS-CoV-2 and other betacoronaviruses

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

An egg-derived SARS-CoV-2 vaccine and treatment for COVID-19 disease

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

Novel AI-based system models the progression of chronic diseases as patients age

Novel AI-based system models the progression of chronic diseases as patients age

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Introducing the PhysioMimix™ OOC Multi-Organ Microphysiological System

Introducing the PhysioMimix™ OOC Multi-Organ Microphysiological System

Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients

Phase I trial evaluates safety, efficacy of astatine for use in alpha therapy for refractory thyroid cancer patients

TXA drug has minimal impact in controlling blood loss in severely injured trauma patients

TXA drug has minimal impact in controlling blood loss in severely injured trauma patients

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

REGEN-COV is effective in preventing severe COVID-19 in immunocompromised individuals

Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease

Model simulations show no need for DEX dose adjustments in COVID-19 patients with liver disease

Promising results from Phase II REGEN-COV study

Promising results from Phase II REGEN-COV study

ACTG announces launch of clinical trial evaluating a three-month TB treatment

ACTG announces launch of clinical trial evaluating a three-month TB treatment

BioIVT to highlight the use of SCHH model to investigate drug-drug interaction of bempedoic acid

BioIVT to highlight the use of SCHH model to investigate drug-drug interaction of bempedoic acid

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

The applications of nanomaterials against viral disease

The applications of nanomaterials against viral disease

SARS-CoV-2 entry inhibitors show antiviral activity

SARS-CoV-2 entry inhibitors show antiviral activity

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced

Results from Phase 0/1 trial of ribociclib plus everolimus in patients with high-grade glioma announced